BPG is committed to discovery and dissemination of knowledge
Retrospective Study
©The Author(s) 2026.
World J Gastroenterol. Jan 14, 2026; 32(2): 113810
Published online Jan 14, 2026. doi: 10.3748/wjg.v32.i2.113810
Table 3 Predictive factors of local recurrence (n = 436 nodules)
Univariable analysis
Multivariable analysis
Multivariable analysis (competing risks)
HR (95%CI)
P value
HR (95%CI)
P value
HR (95%CI)
P value
Age (years)1.03 (1.002-1.06)0.0371.02 (0.99-1.05)0.1921.02 (0.98-1.06)0.15
Sex (male vs female)0.62 (0.31-1.25)0.182----
Child Pugh (B vs A)1.85 (0.94-3.65)0.0741.55 (0.75-3.2)0.2330.72 (0.27-1.95)0.52
Platelet count (for 50.000 additional platelet)1.09 (0.90-1.33)0.376----
AFP (for 100 ng/mL additional)1.10 (1.08-1.13)< 0.0011.05 (0.99-1.11)0.0801 (0.94-1.01)0.48
Tumor size (mm)1.08 (1.06-1.11)< 0.0011.08 (1.05-1.11)< 0.0011.07 (1.05-1.1) 0.06
Subcapsular HCC0.97 (0.60-1.57)0.900----
Proximity of HCC to large vessels1.29 (0.68-2.42)0.4351.34 (0.69-2.59)0.3931.14 (0.59-2.2)0.7
Number of HCC nodules0.88 (0.71-1.08)0.224----
Treatment by ultrasound guidance alone0.40 (0.10-1.59)0.193----
Treatment by ultrasound and CT guidance0.92 (0.22-3.79)0.908----
Operator experience (per additional month)1.00 (0.998-1.002)0.9631.00 (0.999-1.002)0.7021.00 (0.999-1)0.9
Thermoablation technique (MWA vs mbp-RFA)2.41 (1.48-3.90)< 0.0012.85 (1.69-4.81)< 0.0012.35 (1.3-4.3)0.005


Write to the Help Desk